Modeling Familial Association of Ages at Onset of Disease in the Presence of Competing Risk

Biometrics

Volumn 66, Issue 4, 2010, Pages 1012-1023

  Shih, Joanna H ^a   Albert, Paul S ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Cause specific cross ratio; Competing risk; Familial association; Odds ratio

Indexed keywords

RISK ASSESSMENT;

BIVARIATE MODELS; CAUSE-SPECIFIC CROSS-RATIO; COMPETING RISKS; CROSS-RATIOS; FAILURE TYPES; FAMILIAL ASSOCIATION; INDEPENDENT CENSORING; MEASURES OF ASSOCIATION; ODD RATIOS; TWO-STAGE ESTIMATIONS;

BIOMETRICS;

AGE CLASS; BIOMETRY; DATA SET; DISEASE INCIDENCE; GENETIC ANALYSIS; HEALTH RISK; HERITABILITY; KINSHIP; NUMERICAL MODEL;

EID: 78650041147     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/j.1541-0420.2009.01372.x     Document Type: Article

References (19)

1. Bandeen-Roche, K. and Liang, K. Y. (2002). Modelling multivariate failure time associations in the presence of a competing risk. Biometrika 89, 299-314.
2. Bandeen-Roche, K. and Ning, J. (2008). Nonparametric estimation of bivariate failure time associations in the presence of a competing risk. Biometrika 95, 221-232.
3. Chatterjee, N., Hartge, P., and Wacholder, S. (2003). Adjustment for competing risk in kin-cohort estimation. Genetic Epidemiology 25, 303-313.
4. Chatterjee, N., Kalaylioglu, Z., Shih, J. H., and Gail, M. (2006). Case-control and case-only designs with genotype and family history data: Estimating relative risk, residual familial aggregation, and cumulative risk. Biometrics 62, 36-48.
5. Cheng, Y. and Fine, J. P. (2008). Nonparametric estimation of cause-specific cross hazard ratio with bivariate competing risks data. Biometrika 95, 233-240.
6. Cheng, Y., Fine, J. P., and Kosorok, M. R. (2007). Nonparametric association analysis of bivariate competing-risks data. Journal of the American Statistical Association 102, 1407-1415.
7. Cheng, Y., Fine, J. P., and Kosorok, M. R. (2009). Nonparametric association analysis of exchangeable clustered competing risks data. Biometrics 65, 385-393.
8. Clayton, D. G. (1978). A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence. Biometrika 65, 141-151.
9. Efron, B. and Tibshirani, R. J. (1993). An Introduction to the Bootstrap. New York Chapman and Hall.
10. Hougaard, P. (2000). Analysis of Multivariate Survival Data. Berlin Springer-Verlag Inc.
11. Hougaard, P., Harvald, B., and Holm, N. V. (1992). Measuring the similarities between the lifetimes of adult Danish twins born between 1881-1930. Journal of the American Statistical Association 87, 17-24.
12. Li, H., Yang, P., and Schwartz, A. G. (1998). Analysis of age of onset data from case-control family studies. Biometrics 54, 1030-1039.
13. Kalbfleisch, J. D. and Prentice, R. L. (2002). The Statistical Analysis of Failure Time Data. New York John Wiley & Sons.
14. Nan, B., Lin, X., Lisabeth, L. D., and Harlow, S. D. (2006). Piecewise constant cross-ratio estimation for association of age at a marker event and age at menopause. Journal of the American Statistical Association 101, 65-77.
15. Oakes, D. (1982). A model for association in bivariate survival data. Journal of the Royal Statistical Society, Series B 44, 414-422.
16. Oakes, D. (1989). Bivariate survival models induced by frailties. Journal of the American Statistical Association 84, 487-493.
17. Prentice, R. L., Kalbfleisch, J. D., Peterson, A. V., Jr, Flournoy, N., Farewell, V. T., and Breslow, N. E. (1978). The analysis of failure times in the presence of competing risks. Biometrics 34, 541-554.
18. Shih, J. H. and Louis, T. A. (1995). Inferences on the association parameter in copula models for bivariate survival data. Biometrics 51, 1384-1399.
19. Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Lawrence, B. C., and Tucker, M. A. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. The New England Journal of Medicine 336, 1401-1408.